Chromatography Resins Market Growth 2022-2030: Increasing Usage of Monoclonal Antibodies in Critical Therapeutic Areas Led to Huge Consumption of Resin in Pharmaceutical Processes

The chromatography resins market size is expected to reach USD 4.81 Billion in 2030 and register a revenue CAGR of 8.0% over the forecast period, according to the latest report by Reports and Data.

The chromatography resins market size is expected to reach USD 4.81 Billion in 2030 and register a revenue CAGR of 8.0% over the forecast period, according to the latest report by Reports and Data. Rapid market revenue growth of chromatography resins is owing to various factors such as increasing demand for therapeutic antibodies, rising concern for food safety, and need for reduction in environmental pollution levels. However, lack of adequate skilled professionals is a restraint that can affect market revenue growth.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/3939

Chromatography has numerous applications in biological and chemical fields. It is widely used in biochemical research to separate and identify chemical compounds of natural origin. Different techniques have been introduced to enhance this process, such as ion-exchange chromatography, affinity chromatography, multimodal, and many more. Ion exchange chromatography is one of the essential adsorption techniques used in separating peptides, proteins, nucleic acids, and related biopolymers, which are charged molecules in different molecular sizes and molecular nature. It provides availability of high capacity stationary phases and sensitive detectors, simple sample preparation, avoidance of hazardous chemicals, decreased sample volumes, flexible reaction options on a changing sample matrix to be analyzed, or the opportunity to operate a complete automated system. Similarly, other techniques are also used in a meaningful manner contributing to the pharmaceutical industry, which can contribute to growth of the market owing to the rise in diseases worldwide and increasing demand for medicines and therapeutics.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times. According to market experts, the pandemic has turned this industry upside down, with an unprecedented rise in demand and acute supply shortage. The report clearly depicts the current global economic landscape and the considerable situation of the healthcare industry. A substantial increase in demand for healthcare services worldwide, rising cases of the SARS-CoV-2 infection, increasing pharmaceutical research & development activities, and new drug pipelines are among the key factors that have driven the global pharma & healthcare industry growth in the recent past. Growing acceptance of telehealth and telemedicine services, rise in government initiatives for COVID-19 vaccine development, and escalating demand for advanced point-of-care diagnostics and home healthcare products have further bolstered the industry growth.

Competitive Landscape:

The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.

Top Companies Profiled in the Report:

Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., GE Healthcare, Purolite Corporation, Mitsubishi Chemical Corporation, W.R. Grace & Co., Merck KGaA, Danaher Corporation, Avantor Inc., Bio-Works Technologies AB.

Get In detailed Research Study @ https://www.reportsanddata.com/report-detail/chromatography-resins-market

Some Key Highlights from the Report

  • Among end-use segments, food & beverage segment is expected to register faster revenue CAGR during the forecast period owing to increasing consumption of chromatography resins in quality control methods. Growing consumer awareness regarding the safety and quality of food and beverage products encourages manufacturers to comprehensively act by rules and regulations of food regulatory authorities. Increase in disposable income and demand for good quality food among individuals is expected to drive revenue growth of this segment.
  • Among technique segments, affinity chromatography segment is expected to register faster revenue CAGR during the forecast period. Most protein purification schemes offer high selectivity, resolution, and capacity. It has the advantage of utilizing a protein’s biological structure or function for purification. The significant applications of affinity chromatography include separating a mixture of compounds, removing impurities in the purification process, enzyme assays, detecting substrates, investigating binding sites of enzymes, in vitro antigen-antibody reactions, and detecting single nucleotide polymorphisms and mutation in nucleic acids. The high demand for protein A resins and Immobilized-metal Affinity Chromatography (IMAC) resins in affinity chromatography technique is expected to drive revenue growth of this segment.
  • Chromatography resins market in North America accounted for largest revenue share in 2021. Industries such as pharmaceuticals, healthcare, food and beverage, and chemicals, where chromatography resins are widely used, have been expanding rapidly in countries in the region. Robust technology infrastructure and financial backing for research and development in the pharmaceutical industry are key driving factors for this region’s market growth. Chromatography resins played a significant role in the analysis and development of Remdesivir in the US, one of the first treatments approved by the U.S. FDA to treat SARS-CoV-2. Such research and development (R&D) initiatives in drug development have increased investment in the chromatography resins field and are expected to continue to support market growth during the forecast period.
  • In January 2022, Merck, a leading science and technology company, signed a definitive agreement to acquire Exelead, a biopharmaceutical contract development and manufacturing organization (CDMO) for approximately USD 780 million. Exelead specializes in complex injectable formulations, including Lipid Nanoparticle-based drug delivery technology which is key in mRNA therapeutics for use in COVID-19 and many other indications. This acquisition would lead to capturing the significant potential of the fast-growing market for mRNA therapies by providing leading CDMO services to their customers.

Download Summary @ https://www.reportsanddata.com/download-summary-form/3939

For the purpose of this report, Reports and Data has segmented chromatography resins market based on type, end-use, technique, and region:

Type Outlook (Revenue, USD Million; 2019–2030)

  • Natural Polymer
  • Synthetic Polymer
  • Inorganic Media

End-use Outlook (Revenue, USD Million; 2019–2030)

  • Pharmaceuticals & Biotechnology
  • Food & Beverage
  • Water & Environmental Analysis
  • Others

Technique Outlook (Revenue, USD Million; 2019–2030)

  • Ion Exchange Chromatography
  • Affinity Chromatography
  • Hydrophobic Interaction Chromatography
  • Size Exclusion Chromatography
  • Multimodal Chromatography
  • Others

Regional Outlook (Revenue, USD Million; 2019–2030)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Israel
    • Rest of MEA

Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/3939

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports By Reports and Data’s:

Active Pharmaceutical Ingredients (API) Market By Type of Synthesis (Synthetic APIs, Biotech APIs), By Type of Manufacturer (Captive APIs, Merchant APIs), By Type (Generic APIs, Innovative APIs), By Application, By Region, And Segment Forecasts, 2016-2027

Anti-inflammatory antibiotics EyeDrops Market By Type (Chloramphenicol, Rifampicin, norfloxacin, Moisten, Erythromycin), By Application (Adult, Children, Others), And Region- Global Forecasts To 2027

Corticosteroid Eyedrops Market Size, Share & Analysis, By Type (Cortisone, Dexamethasone, Tobradex, Others), By Application (Adult, Children), and By Region, Forecast To 2028

Drainage Bottle Market Size, Share & Analysis, By Product Type (Urinary Drainage Bottles, Chest Drainage Bottles, Others), By Capacity (400 Ml, 600 Ml, Others), By Application (Thoracic Surgery, Uremia Treatment, Wound Treatment, Others), And By Region, Forecast To 2027

EEG and ECG Biometrics Market By Product Type (EEG and ECG), By Application (Healthcare, Government, Financial, Banking, and Others), and By Region Forecast to 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs